GRAFT SURVIVAL

Clinical trials for GRAFT SURVIVAL explained in plain language.

Never miss a new study

Get alerted when new GRAFT SURVIVAL trials appear

Sign up with your email to follow new studies for GRAFT SURVIVAL, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 2

UCLA tests stem cell trick to end lifelong Anti-Rejection drugs for liver transplants

Disease control Recruiting now

This study tests a new approach to help liver transplant recipients stop taking toxic anti-rejection drugs for good. Twelve adults who received a liver from a living donor at least one year ago will get a donor stem cell infusion after a mild radiation and antibody treatment. The…

Matched conditions: GRAFT SURVIVAL

Phase: PHASE1, PHASE2 • Sponsor: University of California, Los Angeles • Aim: Disease control

Last updated May 11, 2026 20:50 UTC

GRAFT SURVIVAL

Get alerted when new GRAFT SURVIVAL trials appear

UCLA tests stem cell trick to end lifelong Anti-Rejection drugs for liver transplants